EN DE

Lenzing Aktiengesellschaft, (LNZ) Fair Value & Analysis

Consumer Cyclical · AT · Market cap €965M

LA Lenzing Aktiengesellschaft, LNZ · VI
Price€23.70
Fair Value€4.44
Upside-81.3%
Quality38/100
Watch Lenzing Aktiengesellschaft, for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -8.5% net margin
Moderate debt · generates free cash flow
Trails peers (3/12)
Narrow moat 22/100
Evidence: Medium Range €1.84 – €7.04 Share as image

Fair value as of: Jul 17, 2026

From 13 valuation models · updated 24 days ago

Share price −4.6% over the past month.

Below-average quality, and screening another 81% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (€7.04). The favourable scenario is already priced in.
  • Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The model range is unusually wide (€1.84 to €7.04). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

€90.33 €19.62 Fair Value €4.44 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range €19.62 – €90.33 · fair‑value band €1.84 – €7.04 · the €23.70 price screens above the €4.44 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Lenzing Aktiengesellschaft, (LNZ) currently trades at €23.70, while our model-based Fair Value estimate is €4.44, implying the stock looks roughly 81.3% overvalued today. The Quality Score stands at 38/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Lenzing Aktiengesellschaft, generated revenue of €2.5B at a net margin of -8.5%. Revenue declined 10.8% year over year. It earns a return on equity of -12.4%. Net debt stands at €230M. Fundamentals as of Jul 17, 2026

Our scenario range runs from €1.84 (bear case) to €7.04 (bull case); at €23.70, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 23% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -27% fair-value upside, at -81%, LNZ screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF €58.80 €74.70 €99.79 80
Rev-Margin DCF €26.01 €31.51 €39.41 74
ROIC Compounder €0.0700 72
All 13 models by family
DCF Models
FCF DCF €57.25 €73.96 €102.53 38
5Y Revenue Exit €26.01 €30.06 €35.83 39
5Y EBITDA Exit €55.41 €80.16 €112.64 41
10Y Revenue Exit €39.03 €44.44 €49.62 36
10Y EBITDA Exit €55.72 €74.71 €95.94 37
Earnings-Based
EPV €0.0700 59
Multiples
EV/EBIT €4.15 €6.75 €9.35 53
EV/EBITDA €63.14 €85.40 €107.66 54
EV/Revenue €3.12 €6.01 €8.91 43
Asset-Based
NCAV (Graham) €12.63 €16.93 €25.27 50
Growth DCF
Growth DCF €58.80 €74.70 €99.79 80
Rev-Margin DCF €26.01 €31.51 €39.41 74
Economic Profit
ROIC Compounder €0.0700 72

Widest divergence: DCF Models (€73.96) versus Multiples (€6.75). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) €2.5B
Revenue growth (YoY) -10.8%
Net margin -8.5%
Return on equity -12.4%
Free cash flow €279M FY2025
Operating margin 6.5%
More key figures
EPS (TTM) €-5.56
EPS growth (YoY) -91.7%
Net debt €230M FY2018

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 38/100

Of which business quality 38 · Market factors (momentum, volatility) 41

Profitability 11
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 55
Earnings quality: real cash, not paper profit
Fin. Strength 25
Balance sheet, leverage, solvency risk
Investment 94
Disciplined investing over empire-building
Low Volatility 48
Calm price path (market factor)
Momentum 39
Price trend over the last 3–12 months (market factor)
52W Momentum 37
Distance to the 52-week high (market factor)
Net Issuance 40
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Lenzing Aktiengesellschaft, together with its subsidiaries, produces and markets regenerated cellulosic fibers for textiles and nonwovens. The company operates through Division Fiber, Division Pulp, and Others segments.

Full company description

Lenzing Aktiengesellschaft, together with its subsidiaries, produces and markets regenerated cellulosic fibers for textiles and nonwovens. The company operates through Division Fiber, Division Pulp, and Others segments. It offers lyocell, modal, and viscose fibers for application in textiles and nonwovens products, such as denim, activewear, intimates, haute couture and footwear, home and interiors, luxury textiles, and workwear; body care, intimate hygiene comprising baby wipes, surface cleaning, beauty and personal care, facial sheet masks, and cosmetic wipes; and protective clothing, engineered products, packaging, filtration as well as medical and industrial applications, and automotive interiors under the TENCEL, VEOCEL, LENZING ECOVERO, and LENZING brand names. The company also provides biorefinery products, including acetic acid biobased, furfural biobased, magnesium-lignosulphonate biobased, soda ash, sodium sulphate, and xylose. In addition, it engages in training and personnel development activities and converts renewable electricity directly into process heat. The company operates in Austria; rest of Europe; Asia; North, Central, and South America; and internationally. Lenzing Aktiengesellschaft was formerly known as Chemiefaser Lenzing AG and changed its name to Lenzing Aktiengesellschaft in 1984. Lenzing Aktiengesellschaft was founded in 1892 and is headquartered in Lenzing, Austria.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Lenzing Aktiengesellschaft, reported revenue of €2.6B in FY2025 versus €2.2B in FY2021, a compound +4.4%/yr. Reported net income was −€172M in FY2025.

Growth Quality 51/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
€2.6B
Latest YoY
−2.3%
Avg. growth/yr (3Y)
+0.5%
Avg. growth/yr (5Y)
+9.8%
Avg. growth/yr (10Y)
+2.6%
Revenue +4.4%/yr
FY21 €2.2B
FY22 €2.6B
FY23 €2.5B
FY24 €2.7B
FY25 €2.6B
Net income
FY21 €139M
FY22 −€44.3M
FY23 −€621M
FY24 −€128M
FY25 −€172M

LNZ screens 81% overvalued. Compare with Shenzhou International Group →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Lenzing Aktiengesellschaft, Fair Value". https://www.fairvalue-calculator.com/stock/LNZ

Peer Group

Textile Manufacturing · 309 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 38 · Bottom 25%
Fair Value upside −81% · Bottom 25%
Return on assets 1% · Below median
Net margin (TTM) -8% · Bottom 25%
Operating margin (TTM) 7% · Above median
Revenue growth -11% · Below median
Debt / equity 0.84× · Higher than 75% of peers

Valuation Multiples vs Textile Manufacturing median · lower = cheaper

P/B 1.14× · Pricier than median
P/S (TTM) 0.44× · Cheaper than median
P/FCF 4.0× · Pricier than 75% of peers
EV/EBITDA 3.8× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 11
FUTURE 0 · sector 0
PAST 0 · sector 14
HEALTH 58 · sector 95
DIVIDEND 0 · sector 34

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Textile Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Shenzhou International Group 2313 HK$44.40 HK$75.65 +70%
Tongkun Group 601233 ¥23.56 ¥14.53 -38%
Inner Mongolia ERDOS Resources Co 600295 ¥12.04 ¥14.35 +19%
HMT (Xiamen) New Technical Materials Co 603306 ¥91.75 ¥12.85 -86%
Far Eastern New Century Corporation 1402 27.55 TWD 28.72 TWD +4%
K.P.R. Mill Limited KPRMILL ₹1,083 ₹467.49 -57%
Zhejiang Orient Holdings 600120 ¥5.18 ¥2.21 -57%
Vardhman Textiles Limited VTL ₹602.20 ₹437.53 -27%
Isiklar Enerji ve Yapi Holding IEYHO 174.20 TRY 323.84 TRY +86%
Shandong Fiberglass Group 605006 ¥16.75 ¥6.42 -62%

Compare Lenzing Aktiengesellschaft, with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Lenzing Aktiengesellschaft, (LNZ) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of €4.44 versus a price of €23.70, about −81% (overvalued).
What is the fair value of LNZ?
Our model-based fair value for Lenzing Aktiengesellschaft, is €4.44 (as of Jul 17, 2026), built from audited fundamentals. The current price is €23.70.
What is the quality score of LNZ?
Lenzing Aktiengesellschaft, has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Lenzing Aktiengesellschaft, (LNZ)?
Lenzing Aktiengesellschaft, reported trailing-twelve-month revenue of about €2.5B (latest available figure, as of Jul 17, 2026).
What is the net profit margin of LNZ?
The net profit margin of Lenzing Aktiengesellschaft, is about -8.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Lenzing Aktiengesellschaft, and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.